5 results for “Patompong Ungprasert”

Research ArticleOpen accessIn the author namesLACTIC ACIDOSIS AND HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: A REVIEW OF THE LITERATURECharat Thongprayoon, Peter J. Edmonds, Patompong Ungprasert et al.Lactic acidosis is the most common cause of anion gap metabolic acidosis and is associated with high morbidity and mortality in hospitalized patients. The association between Hemophagocytic Lymphohistiocytosis (HLH) and lactic acidosis is still unclear. HLH causes cytokine overproduction which in turn induces lactic acidosis. There have been only few reports of type B lactic acidosis in HLH patients. There … …Current Research in Medicine, Vol. 5, Issue 2 · 5 Jul 2014 · 7,687 accessesView PDF Cite

Research ArticleOpen accessIn the author namesChronic Kidney Disease-Mineral Bone Disoder: Fibroblast Growth Factor-23 and Phosphate MetabolismWisit Cheungpasitporn, Pongsathorn Kue-A-Pai, Patompong Ungprasert et al.Chronic Kidney Disease (CKD) is a growing epidemic in the United States. There are hormonal changes that develop long before the mineral changes in patients with CKD occur. Increased Parathyroid Hormone (PTH) levels first become evident when the estimated Glomerular Filtration Rate (eGFR) is below 60 mL/min/1.73m2. High serum phosphate stimulates the secretion of the Fibroblast Growth Factor 23 (FGF-23) … …Current Research in Medicine, Vol. 4, Issue 1 · 4 May 2013 · 6,882 accessesView PDF Cite

Research ArticleOpen accessIn the author namesWhat Is The “Safest” Non-Steroidal Anti-Inflammatory Drugs?Patompong Ungprasert, Wonngarm Kittanamongkolchai, Chrystal Price et al.Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) which are widely used in clinical practice are also very well-known for their various adverse reactions. Each NSAID has its own unique safety profile and selecting an appropriate NSAID must be individualized for each patient based on his or her medical needs and risk factors. We reviewed literatures on NSAIDs, focusing on their adverse reaction profile. … …Current Research in Medicine, Vol. 3, Issue 2 · 18 Jun 2012 · 16,268 accessesView PDF Cite

Research ArticleOpen accessIn the author namesIn-Depth Review of Stroke Prevention in Patients with Non-Valvular Atrial FibrillationDaych Chongnarungsin, Supawat Ratanapo, Narat Srivali et al.Stroke is a common complication of atrial fibrillation that leads to high morbidity. Anticoagulation therapy significantly reduces the risk of stroke in a selected group of patients. The decision to start anticoagulation needs to be balanced with bleeding risk. During the past years, multiple oral anticoagulation agents were proven to be as effective as warfarin in multiple randomized clinical trials. … …Current Research in Medicine, Vol. 3, Issue 2 · 22 May 2012 · 12,570 accessesView PDF Cite